A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...

Over the last several days, the safety and efficacy of messenger RNA, or mRNA, vaccines have come under intense scrutiny. On Tuesday, the U.S. Food and Drug Administration announced plans to limit ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.4% in the afternoon session after a major long-term study from ...

An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...

More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...

TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...

SAN ANTONIO – The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health experts. “The news that we’re going to block a Nobel ...

On first glance, the data that Health and Human Services Secretary Robert F. Kennedy Jr. cited to justify canceling some $500 million in federal grants for mRNA vaccine research looked impressive. The ...

Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to terminate nearly $500 million in government funding for mRNA vaccine development has alarmed public health experts. “This is a ...

The United States may be losing its edge in mRNA technology­­. The technology, which powered life-saving COVID-19 vaccines and is now rocketing new cancer therapeutics forward, will soon undergo a ...